CareDx Statistics
Total Valuation
CareDx has a market cap or net worth of $1.12 billion. The enterprise value is $945.50 million.
Important Dates
The last earnings date was Tuesday, April 28, 2026, after market close.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CareDx has 51.22 million shares outstanding. The number of shares has decreased by -9.13% in one year.
| Current Share Class | 51.22M |
| Shares Outstanding | 51.22M |
| Shares Change (YoY) | -9.13% |
| Shares Change (QoQ) | +3.92% |
| Owned by Insiders (%) | 4.27% |
| Owned by Institutions (%) | 101.33% |
| Float | 49.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 27.91 |
| PS Ratio | 2.73 |
| Forward PS | 2.53 |
| PB Ratio | 3.69 |
| P/TBV Ratio | 4.67 |
| P/FCF Ratio | 17.36 |
| P/OCF Ratio | 15.43 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 408.24, with an EV/FCF ratio of 14.58.
| EV / Earnings | n/a |
| EV / Sales | 2.29 |
| EV / EBITDA | 408.24 |
| EV / EBIT | n/a |
| EV / FCF | 14.58 |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.40 |
| Quick Ratio | 2.93 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 1.85 |
| Debt / FCF | 0.28 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.36% and return on invested capital (ROIC) is -8.78%.
| Return on Equity (ROE) | -2.36% |
| Return on Assets (ROA) | -1.80% |
| Return on Invested Capital (ROIC) | -8.78% |
| Return on Capital Employed (ROCE) | -3.92% |
| Weighted Average Cost of Capital (WACC) | 17.94% |
| Revenue Per Employee | $539,634 |
| Profits Per Employee | -$10,708 |
| Employee Count | 765 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 5.21 |
Taxes
In the past 12 months, CareDx has paid $181,000 in taxes.
| Income Tax | 181,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.56% in the last 52 weeks. The beta is 2.54, so CareDx's price volatility has been higher than the market average.
| Beta (5Y) | 2.54 |
| 52-Week Price Change | +18.56% |
| 50-Day Moving Average | 18.50 |
| 200-Day Moving Average | 16.74 |
| Relative Strength Index (RSI) | 64.31 |
| Average Volume (20 Days) | 751,754 |
Short Selling Information
The latest short interest is 6.40 million, so 12.49% of the outstanding shares have been sold short.
| Short Interest | 6.40M |
| Short Previous Month | 6.42M |
| Short % of Shares Out | 12.49% |
| Short % of Float | 13.04% |
| Short Ratio (days to cover) | 10.45 |
Income Statement
In the last 12 months, CareDx had revenue of $412.82 million and -$8.19 million in losses. Loss per share was -$0.16.
| Revenue | 412.82M |
| Gross Profit | 284.37M |
| Operating Income | -13.00M |
| Pretax Income | -8.01M |
| Net Income | -8.19M |
| EBITDA | 2.32M |
| EBIT | -13.00M |
| Loss Per Share | -$0.16 |
Full Income StatementBalance Sheet
The company has $187.18 million in cash and $17.84 million in debt, giving a net cash position of $180.24 million or $3.52 per share.
| Cash & Cash Equivalents | 187.18M |
| Total Debt | 17.84M |
| Net Cash | 180.24M |
| Net Cash Per Share | $3.52 |
| Equity (Book Value) | 313.54M |
| Book Value Per Share | 6.11 |
| Working Capital | 190.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $72.95 million and capital expenditures -$8.10 million, giving a free cash flow of $64.85 million.
| Operating Cash Flow | 72.95M |
| Capital Expenditures | -8.10M |
| Depreciation & Amortization | 15.32M |
| Net Borrowing | n/a |
| Free Cash Flow | 64.85M |
| FCF Per Share | $1.27 |
Full Cash Flow StatementMargins
Gross margin is 68.88%, with operating and profit margins of -3.15% and -1.98%.
| Gross Margin | 68.88% |
| Operating Margin | -3.15% |
| Pretax Margin | -1.94% |
| Profit Margin | -1.98% |
| EBITDA Margin | 0.56% |
| EBIT Margin | -3.15% |
| FCF Margin | 15.71% |